These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 15862291

  • 41. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
    Bach P, Tschäpe JA, Kopietz F, Braun G, Baade JK, Wiederhold KH, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, Müller UC.
    J Immunol; 2009 Jun 15; 182(12):7613-24. PubMed ID: 19494285
    [Abstract] [Full Text] [Related]

  • 42. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
    Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ.
    Biogerontology; 2008 Dec 15; 9(6):405-20. PubMed ID: 18679819
    [Abstract] [Full Text] [Related]

  • 43. [Treatment of Alzheimer disease: A beta vaccine].
    Tabira T, Hara H.
    Rinsho Shinkeigaku; 2004 Nov 15; 44(11):778-80. PubMed ID: 15651289
    [Abstract] [Full Text] [Related]

  • 44. Cerebral hemorrhage after passive anti-Abeta immunotherapy.
    Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M.
    Science; 2002 Nov 15; 298(5597):1379. PubMed ID: 12434053
    [No Abstract] [Full Text] [Related]

  • 45. [Alzheimer's disease: latest news on immunization].
    Lacomblez L.
    Psychol Neuropsychiatr Vieil; 2003 Dec 15; 1(4):287-8. PubMed ID: 15688537
    [No Abstract] [Full Text] [Related]

  • 46. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
    Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M.
    Adv Exp Med Biol; 2015 Dec 15; 863():79-94. PubMed ID: 26092627
    [Abstract] [Full Text] [Related]

  • 47. Relevance of quantitative measurements of anti-Abeta antibodies in therapeutic intravenous immunoglobulin using synthetic peptides.
    Jorquera JI.
    Int Immunopharmacol; 2010 Mar 15; 10(3):373-4; author reply 375-6. PubMed ID: 20018258
    [No Abstract] [Full Text] [Related]

  • 48. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR, Cathcart ES.
    Lab Invest; 1980 Jun 15; 42(6):663-7. PubMed ID: 7392571
    [Abstract] [Full Text] [Related]

  • 49. Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice.
    Lemere CA, Spooner ET, Leverone JF, Mori C, Iglesias M, Bloom JK, Seabrook TJ.
    Neurochem Res; 2003 Jul 15; 28(7):1017-27. PubMed ID: 12737526
    [Abstract] [Full Text] [Related]

  • 50. An animal model of vascular amyloidosis.
    Ghiso J, Wisniewski T.
    Nat Neurosci; 2004 Sep 15; 7(9):902-4. PubMed ID: 15332087
    [No Abstract] [Full Text] [Related]

  • 51. Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?
    Aisen PS, Vellas B.
    J Nutr Health Aging; 2013 Jan 15; 17(1):49-50. PubMed ID: 23299379
    [No Abstract] [Full Text] [Related]

  • 52. [Vaccination against Alzheimer disease?].
    Blasko I, Grubeck-Loebenstein B.
    Wien Klin Wochenschr; 2003 May 15; 115(9):279-80. PubMed ID: 12793027
    [No Abstract] [Full Text] [Related]

  • 53. Immunization for Alzheimer's disease: a shot in the arm or a whiff?
    Levey AI.
    Ann Neurol; 2000 Oct 15; 48(4):553-5. PubMed ID: 11026438
    [No Abstract] [Full Text] [Related]

  • 54. Immunoglobulin content of experimentally induced amyloid in hamsters.
    Zółtowska A, Slusarczyk J.
    Arch Immunol Ther Exp (Warsz); 1979 Oct 15; 27(1-2):9-13. PubMed ID: 444045
    [Abstract] [Full Text] [Related]

  • 55. On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications.
    Inyushin M, Zayas-Santiago A, Rojas L, Kucheryavykh L.
    Front Immunol; 2020 Oct 15; 11():571083. PubMed ID: 33123145
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Role of immunological phenomena during experimental amyloidosis induced by sodium caseinate in mice].
    Stora C, Lespinats G.
    Arch Anat Histol Embryol; 1971 Oct 15; 54(1):77-86. PubMed ID: 4949727
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. An opportunity lost.
    Nature; 2004 Aug 12; 430(7001):709. PubMed ID: 15306769
    [No Abstract] [Full Text] [Related]

  • 60. Cytokines and Alzheimer's disease.
    Chaldakov GN.
    Immunol Today; 1992 Jun 12; 13(6):237. PubMed ID: 1627252
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.